Aardvark Therapeutics, Inc. (AARD)
Pharmaceutical Preparations
Latest Price
$5.55
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.43
P/B Ratio
1.62
Institutional Ownership
42.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Decheng Capital LLC | 3.92M | $22.0M | 17.90% | -- | 2026-06-30 |
| CITADEL ADVISORS LLC | 1.34M | $7.0M | 6.13% | +46.6K | 2026-06-30 |
| Laurion Capital Management LP | 1.03M | $5.0M | 4.73% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 562.9K | $3.0M | 2.57% | +8.8K | 2026-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 480.2K | $2.0M | 2.19% | +345.8K | 2026-06-30 |
| EcoR1 Capital, LLC | 410.9K | $2.0M | 1.88% | -- | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300.0K | $1.0M | 1.37% | -- | 2026-06-30 |
| BlackRock, Inc. | 187.0K | $1.0M | 0.85% | -605.5K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 149.8K | -- | 0.68% | -159.6K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 108.4K | -- | 0.50% | -- | 2026-06-30 |